| CVE |
Vendors |
Products |
Updated |
CVSS v3.1 |
| Adobe Photoshop versions CC 2017 (18.0.1) and earlier, CC 2015.5.1 (17.0.1) and earlier have an unquoted search path vulnerability. |
| A DLL Hijacking vulnerability in QNAP Qsync for Windows (exe) version 4.2.2.0724 and earlier could allow remote attackers to execute arbitrary code on Windows machines. |
| Adobe Shockwave versions 12.2.7.197 and earlier have an insecure library loading (DLL hijacking) vulnerability. Successful exploitation could lead to escalation of privilege. |
| A vulnerability in the Cisco FindIT Network Discovery Utility could allow an authenticated, local attacker to perform a DLL preloading attack, potentially causing a partial impact to the device availability, confidentiality, and integrity, aka Insecure Library Loading. The vulnerability is due to the application loading a malicious copy of a specific, nondefined DLL file instead of the DLL file it was expecting. An attacker could exploit this vulnerability by placing an affected DLL within the search path of the host system. An exploit could allow the attacker to load a malicious DLL file into the system, thus partially compromising confidentiality, integrity, and availability on the device. Cisco Bug IDs: CSCvf37955. |
| Format Factory 4.1.0 has a DLL Hijacking Vulnerability because an untrusted search path is used for msimg32.dll, WindowsCodecs.dll, and dwmapi.dll. |
| An untrusted search path (aka DLL Preloading) vulnerability in the Cisco Immunet antimalware installer could allow an authenticated, local attacker to execute arbitrary code via DLL hijacking if a local user with administrative privileges executes the installer in the current working directory where a crafted DLL has been placed by an attacker. The vulnerability is due to incomplete input validation of path and file names of a DLL file before it is loaded. An attacker could exploit this vulnerability by creating a malicious DLL file and installing it in a specific system directory. A successful exploit could allow the attacker to execute commands on the underlying Microsoft Windows host with privileges equivalent to the SYSTEM account. An attacker would need valid user credentials to exploit this vulnerability. Cisco Bug IDs: CSCvf23928. |
| Code injection vulnerability in AVG Ultimate 17.1 (and earlier), AVG Internet Security 17.1 (and earlier), and AVG AntiVirus FREE 17.1 (and earlier) allows a local attacker to bypass a self-protection mechanism, inject arbitrary code, and take full control of any AVG process via a "DoubleAgent" attack. One perspective on this issue is that (1) these products do not use the Protected Processes feature, and therefore an attacker can enter an arbitrary Application Verifier Provider DLL under Image File Execution Options in the registry; (2) the self-protection mechanism is intended to block all local processes (regardless of privileges) from modifying Image File Execution Options for these products; and (3) this mechanism can be bypassed by an attacker who temporarily renames Image File Execution Options during the attack. |
| IBM WebSphere Message Broker could allow a local user with specialized access to prevent the message broker from starting. IBM X-Force ID: 122033. |
| Multiple unquoted service path vulnerabilities in Sierra Wireless Windows Mobile Broadband Driver Package (MBDP) with build ID < 4657 allows local users to launch processes with elevated privileges. |
| Untrusted search path vulnerability in HIBUN Confidential File Decryption program prior to 10.50.0.5 allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. Note this is a separate vulnerability from CVE-2017-10863. |
| Untrusted search path vulnerability in Installer of HIBUN Confidential File Viewer prior to 11.20.0001 allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in HIBUN Confidential File Decryption program prior to 10.50.0.5 allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. Note this is a separate vulnerability from CVE-2017-10865. |
| Untrusted search path vulnerability in "i-filter 6.0 installer" timestamp of code signing is before 23 Aug 2017 (JST) allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in Installer for Shin Kikan Toukei Houkoku Data Nyuryokuyou Program (program released on 2013 September 30) Distributed on the website until 2017 May 17 allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in TDB CA TypeA use software Version 5.2 and earlier, distributed until 10 August 2017 allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in Installer of Flets Easy Setup Tool Ver1.2.0 and earlier allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in "i-filter 6.0 install program" file version 1.0.8.1 and earlier allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in FENCE-Explorer for Windows V8.4.1 and earlier allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| Untrusted search path vulnerability in Installer for ContentsBridge Utility for Windows 7.4.0 and earlier allows an attacker to gain privileges via a Trojan horse DLL in an unspecified directory. |
| An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient. |
